Defence Therapeutics Inc.
DTC
Rankning i aktier
#29446
Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a... Headquartered in Vancouver, Canada, Defence Therapeutics Inc. is a biotechnology company founded in 2017. This firm focuses on pioneering biological and biosimilar therapeutic solutions for both cancer and infectious diseases. A cornerstone of its approach is the exclusive ACCUM™ technology, engineered to precisely and safely transport vaccine antigens or antibody-drug conjugates (ADCs) directly to their intended cellular targets. The company's development efforts span several key areas: novel dendritic cell vaccines for various cancers, protein-based vaccines addressing COVID-19 and other infectious ailments, and specialized antibody-drug conjugate products aimed at different cancer types. Defence Therapeutics Inc. adopted its current name in March 2020, having previously operated as Accum Therapeutics Inc.
Aktiekurs
$0.26788696
Marknadsvärde
$20.30M
Förändring (1 dag)
-3.95%
Förändring (1 år)
-54.23%
Land
CA
Handel Defence Therapeutics Inc. (DTC)
Kategori
Healthcare
Historik för aktiesplit för Defence Therapeutics Inc. (DTC)
Aktien Defence Therapeutics Inc. (symbol: DTC) har genomgått totalt 0 aktiesplitar.
Den senaste spliten skedde den Oct 20, 2026.
En DTC-aktie köpt före Oct 20, 2026 motsvarar nu 0 DTC-aktier.
Den senaste spliten skedde den Oct 20, 2026.
En DTC-aktie köpt före Oct 20, 2026 motsvarar nu 0 DTC-aktier.
Lista över aktiesplitar
| År | Split | Multipel | Kumulativ multipel |
|---|---|---|---|
| Inte tillräckligt med data för de angivna datumen. | |||
Aktiesplitar för liknande företag eller konkurrenter
| Företag | Antal aktiesplitar | Kumulativ multipel | Land |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
